CAMPER: mechanistic artificial intelligence for designing peptides that target MRSA persisters.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41803147.
- Also identified by DOI 10.1038/s41467-026-70348-9 and PMC identifier 13100222.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Developing short, stable, and potent antimicrobial peptides is a promising strategy to combat antibiotic resistance and persistence. We present CAMPER (Constraint-driven AMP Engineering with Ranking), a mechanistic artificial intelligence framework that integrates machine learning with biophysical ranking to prioritize membrane-targeting peptides effective against persister and biofilm forms of methicillin-resistant Staphylococcus aureus. We apply CAMPER to identify WP-CAMPER1 (12mer) that kills S. aureus MW2 at a minimal inhibitory concentration of 4 µg/mL. A 2% topical WP-CAMPER1 formulation reduces S. aureus MW2 burden by 2.5 log<sub>10</sub> (p < 0.0002) in a murine prophylactic skin infection model, while its D-enantiomer, WP-CAMPER1-d, achieves 1.37 log<sub>10</sub> (p < 0.0001) reduction in an established biofilm infection model. Single-cell analysis using a high-throughput microfluidic system shows that WP-CAMPER1-d reduces exponential-phase persisters of S. aureus USA300, and, in a deep-seated murine thigh infection model, decreases stationary-phase S. aureus MW2 persisters by 1.6 log<sub>10</sub> (p < 0.0001).
Medical subject headings
- Methicillin-Resistant Staphylococcus aureus
- Artificial Intelligence
- Anti-Bacterial Agents
- Antimicrobial Peptides